The PsilWell study is a Health Canada–approved clinical trial offering legal, guided access to psilocybin-assisted psychotherapy. Unlike traditional pharmaceutical trials, it’s community-funded and run with TheraPsil, a nonprofit that has trained more than 700 psychedelic therapists since 2019. Participants receive one supervised psilocybin dosing session supported by group therapy before and after the experience. The 7-week program combines medical oversight with expert therapeutic care, allowing participants to safely explore psilocybin’s potential benefits while contributing to groundbreaking mental health research in Canada.